Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what — from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,397 filings

Top spenders & firms Spend by issue

Clear
Q4
NATIONAL FAMILY PLANNING AND REPRODUCTIVE HEALTH ASSOCIATION for NATIONAL FAMILY PLANNING AND REPRODUCTIVE HEALTH ASSOCIATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Medicare/Medicaid, Family issues/Abortion/Adoption, Pharmacy
View →
Q3
MUSCULAR DYSTROPHY ASSOCIATION, INC. for MUSCULAR DYSTROPHY ASSOCIATION, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Illinois · House · Senate
Labor Issues/Antitrust/Workplace, Health Issues, Aviation/Airlines/Airports, Budget/Appropriations
View →
Q4
AMERICAN COLLEGE OF CLINICAL PHARMACY for AMERICAN COLLEGE OF CLINICAL PHARMACY
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Pharmacy, Medicare/Medicaid, Health Issues, Education
View →
Q4
AMERICAN PHARMACISTS ASSOCIATION for AMERICAN PHARMACISTS ASSOCIATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Pharmacy
View →
Q4
MCDERMOTT+ LLC for ALLIANCE FOR RURAL HOSPITAL ACCESS
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q4
CORNERSTONE GOVERNMENT AFFAIRS, INC. for CHILDREN'S NATIONAL MEDICAL CENTER
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $50,000.00 income
Health Issues, Budget/Appropriations, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q4
TAUZIN STRATEGIC NETWORKS for RAZORMETRICS
4th Quarter (Oct 1 - Dec 31) 2025 · Texas · House · Senate · $37,500.00 income
Medicare/Medicaid, Pharmacy
View →
Q4
REPUBLIC CONSULTING, LLC for IQVIA
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $60,000.00 income
Medical/Disease Research/Clinical Labs, Pharmacy, Health Issues
View →
RR
MR. DAVID FRIEDMAN for TEVA PHARMACEUTICALS USA, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey
Pharmacy, Manufacturing
View →
Q3
MR. H.R. BERT PENA for MARGO RX LLC(DBA RICHARD'S PHARMACY)
3rd Quarter (July 1 - Sep 30) 2025 · Texas · House
Pharmacy
View →
RR
BALLARD PARTNERS for MADRIGAL PHARMACEUTICALS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania
Pharmacy
View →
RA
SHIONOGI INC. for SHIONOGI INC.
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey
Budget/Appropriations, Health Issues, Medical/Disease Research/Clinical Labs, Insurance
View →
RR
WILLIAMS AND JENSEN, PLLC for NOVOCURE INC.
4th Quarter (Oct 1 - Dec 31) 2025 · New Hampshire
Pharmacy, Veterans
View →
Q3
ACADEMY OF MANAGED CARE PHARMACY for ACADEMY OF MANAGED CARE PHARMACY
3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate
Medicare/Medicaid, Pharmacy
View →
Q3
THE HEALTH EQUITY STRATEGIES GROUP, LLC for TRAVERE THERAPEUTICS
3rd Quarter (July 1 - Sep 30) 2025 · California · House · $16,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Pharmacy
View →
RR
BALLARD PARTNERS for SENIOR CARE PHARMACY, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Alabama
Pharmacy
View →
RR
ARNOLD & PORTER KAYE SCHOLER LLP for SPYRE THERAPEUTICS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts
Medical/Disease Research/Clinical Labs, Pharmacy, Health Issues
View →
RR
TSG ADVOCATES DC, LLC for BELCHER PHARMACEUTICALS LLC
4th Quarter (Oct 1 - Dec 31) 2025 · Florida
Pharmacy, Government Issues
View →
RR
MICHAEL BEST STRATEGIES LLC for SHARX
4th Quarter (Oct 1 - Dec 31) 2025 · Missouri
Health Issues, Pharmacy, Trade (domestic/foreign)
View →
RR
BUCHANAN INGERSOLL & ROONEY PC for VIDRINE PHARMACEUTICAL GROUP, LLC D/B/A BOUDREAUXS NEW DRUG STORE
4th Quarter (Oct 1 - Dec 31) 2025 · Louisiana
Pharmacy
View →
Q3
RAY ANDERSON for 340B HEALTH
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House
Medicare/Medicaid, Pharmacy, Health Issues
View →
Q3
CHRISTOPHER HEINZ for UNITED BROTHERHOOD OF CARPENTERS AND JOINERS OF AMERICA
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $45,000.00 income
Retirement, Pharmacy, Labor Issues/Antitrust/Workplace, Health Issues
View →
Q3
CHRISTOPHER HEINZ for PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION
3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · $30,000.00 income
Pharmacy
View →
Q3
PANNONE LOPES DEVEREAUX & O'GARA LLC for AMGEN
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · $9,000.00 income
Pharmacy
View →
Q3
SURESCRIPTS for SURESCRIPTS
3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate
Health Issues, Pharmacy
View →
Previous Page 15 of 56 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem